// App-Quantinova.ai

: Optimal Medical Therapy in Heart Failure: Reasons for Lack of Medication Titration in the GUIDE IT Trial

Researchers

Presenter

  • Mona Fiuzat

Principal Investigators

  • Wendimagegn Alemayehu

  • Justin Ezekowitz

  • Cindy Westerhout

  • David Whellan

  • Hillary Mulder

  • Tariq Ahmad

  • Kirkwood Adams

  • Ileana Pina

  • Kevin Anstrom

  • Lawton Cooper

  • Brooke Alhanti

  • Marco Sbolli

  • Daniel Mark

  • Eric Leifer

  • Michael Felker

  • Christopher O'Connor

  • James Januzzi

Medical Centers

  • Duke University, Durham, NC

  • Canadian VIGOUR Centre, Alberta, ON, Canada

  • Thomas Jefferson University, Philadelphia, PA

  • Yale University, New Haven, CT

  • UNC, Chapel Hill, NC

  • R&D Detroit VA Medical Ctr, Detroit, MI

  • CCR, NIH, Bethesda, MD

  • Inova Heart and Vascular Inst, Falls Church, VA

  • Massachusetts General Hospital, Boston, MA

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Congestive heart failure

  • Heart failure with reduced ejection fraction

Biomarkers

  • N-terminal pro b-type natriuretic peptide

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved